Eurosurveillance banner


Eurosurveillance invites authors to submit papers for a special issue on HIV/AIDS and other sexually transmitted infections (STI) in men who have sex with men (MSM). The topic is in line with the main theme of World AIDS Day 2009 events organised by the European Centre for Disease Prevention and Control and aims at drawing attention to the epidemiological importance of MSM in HIV and other STI and directing the ECDC activities to focus on main risk groups.

Eurosurveillance is planning to publish a special issue on Socio-economic determinants and infections diseases in Europe in spring 2010. For this reason Eurosurveillance invites interested scientists who have research findings in the area to submit papers for review and possible publication. The submission deadline now is 15 November.

The data from 27 European Union countries plus Iceland, Liechtenstein and Norway show that considerable progress has been made in preventing and controlling the disease. The number of newly diagnosed cases and the overall notification rate declined continuously in the past decade, and the notification rate in 2007 was 12% lower than in 2003. In spite of this decline, a total of 84,917 new cases of TB were registered in 2007 and a number of challenges hamper the progress towards the elimination of TB in the EU.

A number of bacterial and viral infections in pregnant women can have serious effects on the unborn child leading to impaired mental and physical health later in life. This week’s issue of Eurosurveillance is dedicated to infectious diseases in pregnancy.

The emergence and spread of antimicrobial resistance (AMR) is a growing problem in many European countries. To mark the very first European Antibiotic Awareness Day, on 18 November, the scientific journal Eurosurveillance runs a series of articles to highlight main aspects of the AMR problem in Europe. They will be published in two issues on 13 and 20 November 2008.

In preparation for the coming influenza season 2008-9, Eurosurveillance publishes a special issue on prevention of influenza by vaccination. Seasonal influenza poses a serious public health threat because of associated serious morbidity and mortality. In Europe, estimates suggest that influenza is responsible for around 40,000 to 220,000 excess deaths, depending on the severity of the epidemic.

Today Eurosurveillance is publishing a special issue dedicated to the widespread advances made in Europe in estimating the real number of newly acquired HIV infections based on an innovative approach called STARHS

To tie in with World Hepatitis Day on 19 May, the scientific journal Eurosurveillance is today publishing a special issue on viral hepatitis, highlighting issues and challenges related to hepatitis B and C.

On 17 April 2008, Eurosurveillance is publishing a special issue with articles on the measles situation in Europe. The publication is linked to European Immunisation Week which runs from 21-27 April.

World Tuberculosis Day on 24 March commemorates the date in 1882 when Robert Koch presented his findings of the causing agent of tuberculosis (TB) – Mycobacterium tuberculosis. In the run up of this day Eurosurveillance publishes a special issue on the situation of TB in Europe.

Today (6 March, 2008), Eurosurveillance, the European peer-reviewed journal of infectious diseases, publishes a special issue on meningococcal disease. It includes two in-depth articles and an editorial by the European Centre for Disease Prevention and Control (ECDC).


In this issue


Home Eurosurveillance Monthly Release  2007: Volume 12/ Issue 9 Article 3 Printer friendly version
Back to Table of Contents
en fr
Previous Next

Eurosurveillance, Volume 12, Issue 9, 01 September 2007
Outbreak report
Pertussis: A cluster of linked cases in the United Kingdom, 2006

Citation style for this article: Weerasinghe C, Fernandes A, Bagaria J. Pertussis: A cluster of linked cases in the United Kingdom, 2006. Euro Surveill. 2007;12(9):pii=729. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=729

 

C Weerasinghe (chisha_wickrema@yahoo.com), A Fernandes, J Bagaria

Thames Valley Health Protection Unit, Oxford, England, United Kingdom


Pertussis is a vaccine-preventable disease with a high rate of complications, especially in young children. It often presents in an atypical fashion in adults and adolescents, making diagnosis difficult. This report describes a cluster of linked cases of three adults and one infant in a family, spread across the United Kingdom (UK). The initial follow-up was of a 20-year-old student with clinical symptoms of pertussis. This diagnosis led to the discovery of two other unvaccinated adult family members with symptoms that fit the case definition for pertussis and a laboratory-confirmed tertiary case in an unvaccinated infant who had to be hospitalised. This report aims to act as a reminder for including pertussis as a differential diagnosis in patients with a long duration of respiratory symptoms and highlights the importance of rapidly identifying and managing close contacts of cases. This is key in protecting the most vulnerable – namely, infants – from infection.

 

Introduction

Pertussis (whooping cough) is a commonly overlooked diagnosis in adults with respiratory symptoms, accounting for infection in 20% of adults presenting with prolonged cough in settings with high immunisation coverage [1]. The bacterial infection caused by Bordetella pertussis is characterised by a prolonged cough (lasting more than two weeks) with paroxysms, inspiratory whoop and post-tussive vomiting. The incubation period varies between six and 20 days and cases are infectious from six days after exposure and may last up to three weeks after the onset of typical paroxysms [2]. Complications of pertussis such as pneumonia and otitis following bacterial superinfection occur usually in childhood; with the highest number occurring in the first six months of life [3]. In adults and adolescents, it often presents atypically, making diagnosis difficult. Adults and school-age children are a known source of infection for younger family members who are too young to be immunised [2].

Pertussis is a vaccine-preventable disease with routine immunisation in the UK given to children at two, three and four months and a subsequent pre-school booster. The vaccine currently in use in the UK is an acellular vaccine that was first introduced in 2001 as a pre-school booster. The Health Protection Agency figures for England and Wales show statutory notifications of pertussis averaging 665 per year over the period 2000-2005, while during 2002-2004 on average 292 of these cases were laboratory confirmed diagnoses (serology, PCR or culture) per year . Increased notification as well as ascertainment has occurred among adults during this time [4].

The following outbreak report describes a cluster of infections affecting mostly adult members of a family and the subsequent infection of an infant. The Oxfordshire Health Protection Team was notified of a case of pertussis in a 20-year-old student in West Yorkshire on 27 October 2006. Contact tracing revealed that she had been in contact with several members of her family over the August Bank Holiday weekend. This article describes the identification and management of the cluster and seeks to highlight the importance of clinical awareness of pertussis in adolescents and adults and the performing of thorough contact tracing.

Methods and results

Outbreak investigation

Index case
The index case was in a 20-year-old university student in West Yorkshire. She developed a cough with post-tussive vomiting on 21 August 2006, which persisted for eight weeks. She had not been immunised against pertussis as a child and was never known to have suffered from pertussis. She had returned from a two-month trip to East Africa two weeks prior to the onset of her symptoms and had no recollection of any contact persons with similar symptoms whilst on the trip. During the three weeks following onset of symptoms, her ‘close/ household contacts’ (Figure 1) were her boyfriend, who lived in the same flat with her, and seven members of her family, who shared the same accommodation with her for three days over the Bank Holiday weekend at the end of August.

Secondary cases
Sister 1 developed a chronic cough with a whoop two weeks after contact with the index case (Figure 1). She was eight months pregnant at the time of contact and symptoms persisted until the week after delivery. However, she did not seek medical attention for her symptoms at any point in time. The investigation revealed that she was not immunised against pertussis during childhood.

Sister 2 also developed symptoms that fit the case definition for pertussis [3], two weeks after the contact with the index case (Figure 1). She presented to her General Practitioner (GP) with these symptoms at the time and was treated with a five-day course of Erythromycin for a suspected chest infection. She was not tested for pertussis and she had also not been immunised against pertussis as a child.

Tertiary case
The baby born to Sister 1, who was symptomatic at the time, developed a cough with apnoeic attacks three weeks after birth (Figure 1) and was admitted to hospital where pertussis was suspected and diagnosed on a nasal swab culture. She was treated with intravenous erythromycin and made an uneventful recovery.

The remaining five contacts in the family (four adults and a three-year-old niece) were fully immunised and did not meet the case definition for pertussis (Figure 1). The boyfriend of the index case was also fully immunised and showed no symptoms.

Measures taken

Following the confirmed diagnosis of pertussis in the three-week-old baby above, the unimmunised mother was treated as a ‘vulnerable contact’ and provided with oral Erythromycin prophylaxis for 10 days. Her husband, who was fully immunised, had symptoms of a non-specific cough at the time and tested negative for B. pertussis. The index case presented to her GP with information that her three-week-old niece had been diagnosed with whooping cough. A blood sample was sent for pertussis PCR and she was commenced on a 10-day course of oral Erythromycin. However, the result of the blood test did not confirm the diagnosis. The negative result could have been due to the delay of over two months between the onset of symptoms and testing. Paired serology would have been a better choice of test given the duration of symptoms [3].

All the other family contacts and the boyfriend remained asymptomatic and did not meet the requirements for prophylaxis as they had all received childhood immunisation.

Discussion

Discussion Professional and public loss of confidence in the pertussis vaccine due to a belief that there was a link to a group of children with brain damage published in a paper in 1974 [2] led to a drop in immunisation coverage of the whole cell pertussis containing DPT vaccine to 30% in 1975 in the UK (Figure 2). Many of those unvaccinated during the late 1970s and 1980s would have been infected with pertussis at this time and the drop in vaccination cover corresponds to the rise in pertussis notifications as shown in Figure 2.

This outbreak report seeks to highlight the importance of suspecting and recognising symptoms of pertussis in the adult population, especially in those who should but may not have been unimmunised during the pertussis vaccine ‘scare’ in the late 1970s. A causal relationship has already been noted with the decrease in vaccination coverage and a following rise in pertussis notifications [5]. We could be seeing a second impact now, 30 years on, with those born in the 1970s and not having been immunised presenting now with pertussis as adults but being diagnosed wrongly with other respiratory illnesses like asthma.

Pertussis is a statutorily notifiable disease, so immunisation history and contact tracing for close contacts in the preceding three weeks of the onset of symptoms in the patient are vital. In the case reported above, this would have led to antibiotic prophylaxis being prescribed to the pregnant sister and possibly the prevention of transmission to the newborn child. Close contacts of pertussis cases who are either unvaccinated, partially vaccinated or under five years of age should be given erythromycin treatment or prophylaxis [6]. The low rates of laboratory confirmation seen nationally compared to the notification rates is probably due to reluctance of physicians to subject patients to a nasopharyngeal swab [8] or the fact that culture diagnosis loses sensitivity with prolonged duration of symptoms [5].

Children and adults might be infected with pertussis even if they were vaccinated in the past because both immunity following vaccination and natural infection wane over time [2]. In the UK, where vaccination coverage by two years of age is currently around 94% [9], pertussis is often overlooked as a differential diagnosis. This is particularly so in adults, as noted above. It is possible that current notification rates that are based on clinical suspicion do not reflect the true incidence of pertussis, especially in the adult population.

Conclusion

This report highlights two major issues with regards to pertussis. Firstly, that a diagnosis of pertussis should form part of the differential diagnosis in any adult with prolonged cough. The sensitivity of this case definition is as high as 84-92% [10].

Secondly, due to the high secondary attack rate associated with unimmunised household contacts, a good family history and prompt notification and testing while providing prophylaxis is crucial in avoiding infection in the most vulnerable population – unimmunised infants.

 


References

  1. Wright SW, Edwards KM, Decker MD, Zeldin MH. Pertussis infection in adults with persistent cough. JAMA 1995; 171: 1044-6.
  2. Health Protection Agency. Whooping Cough (Pertussis). Available from: http://www.hpa.org.uk/infections/topics_az/whoopingcough/gen_info.htm (accessed on 24/07/2007).
  3. Crowcroft NS, Pebody RG. Recent developments in pertussis. The Lancet - Vol. 367, Issue 9526, 10 June 2006, Pages 1926-1936.
  4. Health Protection Agency. Epidemiological data – Whooping Cough (Pertussis). Available from: http://www.hpa.org.uk/infections/topics_az/whoopingcough/data_not_age.htm (accessed on 01/09/2007)
  5. Gangarosa E, Galazka A, Wolfe C, Phillips L, Gangarosa R, Miller E, Chen R. Impact of anti-vaccine movements on pertussis control: the untold story. The Lancet - Vol. 351, Issue 9099, 31 January 1998, Pages 356-361.
  6. Dodhia H, Crowcroft NS, Bramley JC, Miller E. UK guidelines for use of erythromycin chemoprophylaxis in persons exposed to pertussis. Journal of Public Health Medicine 2002;24:200-206.
  7. Health Protection Agency. Whooping Cases & Vaccine Coverage England and Wales 1940–2005 Q3. Available from: http://www.hpa.org.uk/infections/topics_az/whoopingcough/images/pert_vacc_cov05.gif (accessed 24/07/2007)
  8. Crowcroft NS, Fry NK, Litt DJ, Harrison TG, George RC, Abid M, et al. Whooping cough – better methods of diagnosis are now available. BMJ Rapid Responses [online] 2007 (accessed 24/07/2007).
  9. The Information Centre. Immunisation statistics, England 2005-2006. Available from: http://www.ic.nhs.uk/pubs/immstats2005to2006 (accessed on 01/03/2007).
  10. Ramsay ME, Farrington CP, Miller E. Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods. Epidemiol Infect 1993;111:41–48.

 



Back to Table of Contents
en fr
Previous Next

Disclaimer:The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the Editorial team or the institutions with which the authors are affiliated. Neither the ECDC nor any person acting on behalf of the ECDC is responsible for the use which might be made of the information in this journal.
The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our Website does not host any form of commercial advertisement.

Eurosurveillance [ISSN] - ©2008 All rights reserved
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.